Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2022

SKU ID : QYR-19427268 | Publishing Date : 29-Oct-2021 | No. of pages : 100

Detailed TOC of Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Hormones and Antagonists
        1.2.3 Microorganism Products
        1.2.4 Plant Products
        1.2.5 Antitumor Antibiotics
        1.2.6 Alkylating Agents
        1.2.7 Antimetabolites
        1.2.8 Natural Products
    1.3 Market by Application
        1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Lung Cancer
        1.3.3 Bladder Cancer
        1.3.4 Breast Cancer
        1.3.5 Cervical Cancer
        1.3.6 Leukemia
        1.3.7 Gynecological Cancer
        1.3.8 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Perspective (2016-2027)
    2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
        2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2016-2021)
        2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2022-2027)
    2.3 Anti-Neoplastic Pharmaceutical Agents Industry Dynamic
        2.3.1 Anti-Neoplastic Pharmaceutical Agents Market Trends
        2.3.2 Anti-Neoplastic Pharmaceutical Agents Market Drivers
        2.3.3 Anti-Neoplastic Pharmaceutical Agents Market Challenges
        2.3.4 Anti-Neoplastic Pharmaceutical Agents Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue
        3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2016-2021)
        3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2016-2021)
    3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
    3.4 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
        3.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2020
    3.5 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
    3.6 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
    3.7 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Type
    4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2016-2021)
    4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2022-2027)

5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application
    5.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Application (2016-2021)
    5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
    6.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
        6.2.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
        6.2.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
        6.2.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
    6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application
        6.3.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
        6.3.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
        6.3.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
    6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
        6.4.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
        6.4.2 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
    7.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type
        7.2.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
        7.2.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
        7.2.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
    7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application
        7.3.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
        7.3.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
        7.3.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
    7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country
        7.4.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
        7.4.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
    8.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type
        8.2.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
    8.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application
        8.3.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
    8.4 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region
        8.4.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
    9.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
        9.2.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
        9.2.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
        9.2.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
    9.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application
        9.3.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
        9.3.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
        9.3.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
    9.4 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country
        9.4.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
        9.4.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size (2016-2027)
    10.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type
        10.2.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2027)
    10.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application
        10.3.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2027)
    10.4 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country
        10.4.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GlaxoSmithKline plc.
        11.1.1 GlaxoSmithKline plc. Company Details
        11.1.2 GlaxoSmithKline plc. Business Overview
        11.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
        11.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.1.5 GlaxoSmithKline plc. Recent Development
    11.2 F. Hoffmann-La Roche Ltd
        11.2.1 F. Hoffmann-La Roche Ltd Company Details
        11.2.2 F. Hoffmann-La Roche Ltd Business Overview
        11.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
        11.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.2.5 F. Hoffmann-La Roche Ltd Recent Development
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Details
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
        11.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.3.5 Eli Lilly and Company Recent Development
    11.4 Bristol-Myers Squibb Company
        11.4.1 Bristol-Myers Squibb Company Company Details
        11.4.2 Bristol-Myers Squibb Company Business Overview
        11.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
        11.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.4.5 Bristol-Myers Squibb Company Recent Development
    11.5 Becton, Dickinson and Company
        11.5.1 Becton, Dickinson and Company Company Details
        11.5.2 Becton, Dickinson and Company Business Overview
        11.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
        11.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.5.5 Becton, Dickinson and Company Recent Development
    11.6 Pfizer Inc.
        11.6.1 Pfizer Inc. Company Details
        11.6.2 Pfizer Inc. Business Overview
        11.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
        11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.6.5 Pfizer Inc. Recent Development
    11.7 Novartis AG
        11.7.1 Novartis AG Company Details
        11.7.2 Novartis AG Business Overview
        11.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
        11.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.7.5 Novartis AG Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
        11.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.8.5 AstraZeneca Recent Development
    11.9 Gilead
        11.9.1 Gilead Company Details
        11.9.2 Gilead Business Overview
        11.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
        11.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
        11.9.5 Gilead Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2022

List of Tables
    Table 1. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Hormones and Antagonists
    Table 3. Key Players of Microorganism Products
    Table 4. Key Players of Plant Products
    Table 5. Key Players of Antitumor Antibiotics
    Table 6. Key Players of Alkylating Agents
    Table 7. Key Players of Antimetabolites
    Table 8. Key Players of Natural Products
    Table 9. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2016-2021)
    Table 13. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2022-2027)
    Table 15. Anti-Neoplastic Pharmaceutical Agents Market Trends
    Table 16. Anti-Neoplastic Pharmaceutical Agents Market Drivers
    Table 17. Anti-Neoplastic Pharmaceutical Agents Market Challenges
    Table 18. Anti-Neoplastic Pharmaceutical Agents Market Restraints
    Table 19. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2016-2021)
    Table 21. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2020)
    Table 22. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
    Table 26. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2016-2021)
    Table 30. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2016-2021)
    Table 34. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
    Table 41. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
    Table 42. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
    Table 47. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2016-2021) & (US$ Million)
    Table 53. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2022-2027) & (US$ Million)
    Table 54. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
    Table 59. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2016-2021) & (US$ Million)
    Table 65. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2022-2027) & (US$ Million)
    Table 66. GlaxoSmithKline plc. Company Details
    Table 67. GlaxoSmithKline plc. Business Overview
    Table 68. GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Product
    Table 69. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 70. GlaxoSmithKline plc. Recent Development
    Table 71. F. Hoffmann-La Roche Ltd Company Details
    Table 72. F. Hoffmann-La Roche Ltd Business Overview
    Table 73. F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Product
    Table 74. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 75. F. Hoffmann-La Roche Ltd Recent Development
    Table 76. Eli Lilly and Company Company Details
    Table 77. Eli Lilly and Company Business Overview
    Table 78. Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Product
    Table 79. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 80. Eli Lilly and Company Recent Development
    Table 81. Bristol-Myers Squibb Company Company Details
    Table 82. Bristol-Myers Squibb Company Business Overview
    Table 83. Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Product
    Table 84. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 85. Bristol-Myers Squibb Company Recent Development
    Table 86. Becton, Dickinson and Company Company Details
    Table 87. Becton, Dickinson and Company Business Overview
    Table 88. Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Product
    Table 89. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 90. Becton, Dickinson and Company Recent Development
    Table 91. Pfizer Inc. Company Details
    Table 92. Pfizer Inc. Business Overview
    Table 93. Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Product
    Table 94. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 95. Pfizer Inc. Recent Development
    Table 96. Novartis AG Company Details
    Table 97. Novartis AG Business Overview
    Table 98. Novartis AG Anti-Neoplastic Pharmaceutical Agents Product
    Table 99. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 100. Novartis AG Recent Development
    Table 101. AstraZeneca Company Details
    Table 102. AstraZeneca Business Overview
    Table 103. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 104. AstraZeneca Recent Development
    Table 105. Gilead Company Details
    Table 106. Gilead Business Overview
    Table 107. Gilead Anti-Neoplastic Pharmaceutical Agents Product
    Table 108. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021) & (US$ Million)
    Table 109. Gilead Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2027
    Figure 2. Hormones and Antagonists Features
    Figure 3. Microorganism Products Features
    Figure 4. Plant Products Features
    Figure 5. Antitumor Antibiotics Features
    Figure 6. Alkylating Agents Features
    Figure 7. Antimetabolites Features
    Figure 8. Natural Products Features
    Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2027
    Figure 10. Lung Cancer Case Studies
    Figure 11. Bladder Cancer Case Studies
    Figure 12. Breast Cancer Case Studies
    Figure 13. Cervical Cancer Case Studies
    Figure 14. Leukemia Case Studies
    Figure 15. Gynecological Cancer Case Studies
    Figure 16. Other Case Studies
    Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered
    Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2027
    Figure 21. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2022-2027)
    Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2020
    Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2020
    Figure 25. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2016-2021)
    Figure 26. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2022-2027)
    Figure 27. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
    Figure 29. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
    Figure 30. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
    Figure 31. United States Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
    Figure 35. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
    Figure 36. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
    Figure 37. Germany Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Share by Region (2016-2027)
    Figure 47. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
    Figure 55. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
    Figure 56. Latin America Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
    Figure 57. Mexico Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Share by Country (2016-2027)
    Figure 63. Turkey Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 67. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 68. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 70. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 71. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 72. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 73. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 74. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed